Data & Intelligence
Health Care Data Insight (Mid-Year 2019)
EMPEA Members, log in and click through for your exclusive access to the detailed report and underlying data.
Responding to expected increases in demand for health care services as income levels rise, emerging market (EM)-focused private capital fund managers deployed USD3.9 billion in the sector during 1H 2019. Following 2018’s record of USD8.7 billion in disclosed capital deployed, investment activity has decreased, year over year, but remains on track to surpass 2017 totals. While EM health care investments are most common in Emerging Asia, health care companies are evolving globally. As evidenced by Boyu Capital and FountainVest Partners’ USD120 million Series B investment in China-based lung cancer drug developer Antengene, EM health care opportunities increasingly involve new technologies and treatments, catering to the unique challenges faced by local populations.
Renuka Ramnath | Founder, Managing Director & Chief Executive Officer, Multiples Alternate Asset Management Private Limited
Brian Lim | Partner and Head of Asia and Emerging Markets, Pantheon Ventures
David Rubenstein | Co-Founder and Co-Executive Chairman, The Carlyle Group
Dr. Andrew Kuper | Founder and CEO, LeapFrog Investments
Torbjorn Caesar | Senior Partner, Actis
Drew Guff | Managing Director & Founding Partner, Siguler Guff & Company